Creative Planning’s Armata Pharmaceuticals ARMP Stock Holding History

Creative Planning’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1	Closed	–	–	4345
2016 Q1	$0	Buy	+1	New	+$513	﹤0.01%	4313
2015 Q4	–	Hold	0	–	–	–	4398
2015 Q3	–	Hold	0	–	–	–	4286

Other funds holding ARMP

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MLM

Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return

Creative Planning's ARMP Position: Q2 2016 in Review

Creative Planning sold out of Armata Pharmaceuticals (ARMP) in Q2 2016, closing a stake of 1 share.

Creative Planning first reported a position in ARMP in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 17 funds tracked by Wall St. Rank hold ARMP as of Q2 2016.

Creative Planning reported no remaining Armata Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Creative Planning sold 1 Armata Pharmaceuticals share in Q2 2016.
Creative Planning first reported a position in Armata Pharmaceuticals in Q1 2016 and held it in 1 quarter.
Creative Planning's Armata Pharmaceuticals position peaked at $0 in Q1 2016.
17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2016.

Based on Creative Planning's 13F filing for Q2 2016, filed 12 Jul 2016.